This report was recently updated on July 20 2024 with the latest and most recent
market numbers
Global Breast Cancer Molecular Diagnostics Market Size, Trends & Analysis - Forecasts to 2028 By Technology (PCR, NGS, In Situ Hybridization), By Application (Small and Medium Sized Enterprises, Large Enterprises), By End-user (Hospitals & Clinics, Diagnostic Centres and Medical Laboratories, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
The global breast cancer molecular diagnostics market is projected to grow at a CAGR of 15.0% from 2023 to 2028.
Molecular diagnostics are used to identify specific genetic and molecular alterations in cancer cells. This approach helps personalized treatment strategies and improved patient outcomes. Breast cancer is one of the most common cancers, worldwide, the early diagnosis is critical for effective treatment. Rising R&D activities for the molecular mechanisms for breast cancer and the development of advanced diagnostic technologies [such as next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), and in situ hybridization (ISH) techniques] enable the growth in adoption of molecular diagnostics used for breast cancer testing.
Growing incidence of breast cancer, worldwide, will further drive the adoption of molecular diagnostics for breast cancer. Additionally, the need for early cancer diagnosis will also help to drive the market growth. The increasing awareness about the benefits of early detection and accurate diagnosis among medical professionals and patients for effective treatment and improved patient outcomes enhances the market growth. It also plays a major role in identifying specific biomarkers and genetic alterations associated with breast cancer, enabling personalized and targeted therapies. In addition, technological advancements and the availability of molecular diagnostic tools increases the demand of molecular diagnostics used for cancer testing. The technologies (such as NGS and PCR) provide researchers and clinicians with enhanced capabilities to detect genetic mutations, gene expression patterns, and molecular subtypes of breast cancer, that helps in precise diagnosis and treatment selection.
Additionally, the growing emphasis on precision medicine and personalized healthcare will further drive the market demand for breast cancer molecular diagnostics. In line with this, each breast cancer patient has a unique molecular profile, and identifying specific genetic alterations & biomarkers that helps in treatment strategies. Molecular diagnostics helps in identifying potential therapeutic targets, predicting treatment response, and monitoring disease progression, that leads to improved patient management and better clinical outcomes. Moreover, the rising awareness and initiatives for early detection & screening programs contribute to the growth of the breast cancer molecular diagnostics market. Pertaining this trend, governments, healthcare organizations, and advocacy groups are promoting breast cancer screening campaigns that creates a higher demand for accurate & sensitive diagnostic tests. In addition, collaborations and partnerships between academic institutions, research organizations, and diagnostic companies drive R&D activities & the development of novel molecular diagnostic assays.
However, the high cost associated with molecular diagnostics tests for breast cancer is expected to restrain the market growth. In line with this, these tests involve complex technologies and require specialized equipment & skilled personnel, that results in high cost for MDx tests. The high cost also poses challenges for healthcare providers and insurance companies in terms of reimbursement and coverage. Complex testing techniques are the other major challenge in the market. These molecular tests required skilled pathologists/molecular biologists who are trained in analysing genomic data. The shortage of trained personnel and the need for ongoing education & training are expected to hinder the market growth during the forecast period.
The PCR segment is registered to be the largest segment in the market from 2023-2028. Growing incidence of breast cancer, worldwide, is driving the demand for effective & accurate diagnostic methods, which will in turn increase the adoption of MDx for breast cancer testing. Pertaining to this trend, PCR offers high sensitivity & specificity, making it an invaluable tool for detecting & monitoring genetic alterations in breast cancer cells. Furthermore, the technological advancements and automation have enhanced the efficiency and throughput of PCR assays, that drives the market growth. The real-time PCR and digital PCR techniques has provided faster and more precise quantification of target DNA molecules. Moreover, the development of automated PCR platforms has simplified the testing process, which reduces human error and increasing the scalability of breast cancer molecular diagnostics.
The screening segment dominated the breast cancer molecular diagnostics, and is expected to have a high growth rate during the forecast period. This is mainly attributed to the rising awareness about the benefits of early detection and the importance of regular breast cancer screening among both healthcare professionals and the patients. Furthermore, educational campaigns and increased media coverage have helped to promote breast cancer screening as an essential component of women's healthcare, leading to greater acceptance & adoption of molecular diagnostic tests. Additionally, favourable reimbursement policies & government initiatives aimed at promoting breast cancer screening enhanced the market of screening segment of the molecular diagnostics market.
The diagnostic centres and medical laboratories segment are registered to be the largest segment in the market from 2023-2028. Also, this is projected to have high growth rate during the forecast period. Technological advancements and the availability of molecular diagnostic tools have enhanced the accuracy and precision of breast cancer testing that helps in high adoption of MDx in diagnostic centres and medical labs. Furthermore, the growing awareness and emphasis on early detection & personalized medicine have fuelled the demand for breast cancer molecular diagnostics in diagnostic centers. Also, growing incidence of breast cancer, coupled with the demand for accurate & timely diagnosis is expected to enhance the growth of diagnostic centers and medical labs segment.
North America holds the largest share in Breast cancer molecular diagnostics. This is primarily attributed to technological advancements and molecular biology that have revolutionized the field of cancer diagnostics (including breast cancer), this will enhance the market growth across the region. Furthermore, the increasing incidence of breast cancer in North America have provided a growing demand for accurate & early detection methods. Also, the rising awareness among healthcare providers and patients about the benefits of molecular diagnostics in breast cancer management has played a significant role in driving market growth further.
Furthermore, Asia Pacific has witnessed a high growth rate during the forecast period. This is mainly attributed to increasing awareness about breast cancer and the importance of early detection has played a critical role. In line with this, technological advancements and the availability of diagnostic tools have fuelled the growth of the breast cancer molecular diagnostics market in APAC. Also, the rising prevalence of breast cancer in the Asia Pacific has contributed to the market growth.
Hologic Inc., Genomic Health (Exact Sciences Corporation), BD, Danaher, Koninklijke Philips N.V., QIAGEN, Thermo Fisher Scientific Inc., Myriad Genetics, Argon Medical Devices, Inc., F. Hoffmann-La Roche Ltd., and Illumina, among others, are some of the key players in the global breast cancer molecular diagnostics market.
Please note: This is not an exhaustive list of companies profiled in the report.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
2.4 Data Metrics on Feed Stocks
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
4 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
4.2 Breast cancer molecular diagnostics market: Technology Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4.1 PCR Market Estimates and Forecast, 2020-2028 (USD Million)
4.5.1 NGS Market Estimates and Forecast, 2020-2028 (USD Million)
4.6.1 In Situ Hybridization Market Estimates and Forecast, 2020-2028 (USD Million)
4.7.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
5 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
5.2 Breast cancer molecular diagnostics market: Application Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4.1 Screening Market Estimates and Forecast, 2020-2028 (USD Million)
5.5.1 Diagnostic and PredictiveMarket Estimates and Forecast, 2020-2028 (USD Million)
5.6.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
6 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET, BY END-USER
6.2 Breast cancer molecular diagnostics market: End-User Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4.1 Hospitals & Clinics Market Estimates and Forecast, 2020-2028 (USD Million)
6.5 Diagnostic Centers and Medical Laboratories
6.5.1 Manufacturing & Production Market Estimates and Forecast, 2020-2028 (USD Million)
6.6.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
7 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET, BY REGION
7.2.1 By Technology Type
7.3.1 By Technology Type
7.3.4.2 U.K. Presered Flowers Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.1 By Technology Type
7.5.1 By Technology Type
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.4.1.1 Business Description & Financial Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2.1 Business Description & Financial Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3.1 Business Description & Financial Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4.1 Business Description & Financial Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Koninklijke Philips N.V.
8.4.5.1 Business Description & Financial Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6.1 Business Description & Financial Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7 THERMO FISHER SCIENTIFIC INC.
8.4.7.1 Business Description & Financial Analysis
8.4.7.3 Products & Services Offered
8.4.7.4 Strategic Alliances between Business Partners
8.4.7.1 Business Description & Financial Analysis
8.4.7.3 Products & Services Offered
8.4.7.4 Strategic Alliances between Business Partners
8.4.9 Argon Medical Devices, Inc.
8.4.8.1 Business Description & Financial Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.10 F. Hoffmann-La Roche Ltd.
8.4.9.1 Business Description & Financial Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.11.1 Business Description & Financial Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9.1.2 Market Scope & SegOrchidtation
9.2 Information ProcureOrchidt
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2.1 Various APPLICATION of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.4 Discussion Guide for Primary Participants
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
10.1 Company Market Share Analysis
10.2 Four Quadrant Positioning Matrix
10.4.1.1 Business Description & Financial Analysis
10.4.1.3 Products & Services Offered
10.4.1.4 Strategic Alliances between Business Partners
10.4.2.1 Business Description & Financial Analysis
10.4.2.3 Products & Services Offered
10.4.2.4 Strategic Alliances between Business Partners
10.4.3.1 Business Description & Financial Analysis
10.4.3.3 Products & Services Offered
10.4.3.4 Strategic Alliances between Business Partners
10.4.4.1 Business Description & Financial Analysis
10.4.4.3 Products & Services Offered
10.4.4.4 Strategic Alliances between Business Partners
10.4.5 Koninklijke Philips N.V.
10.4.5.1 Business Description & Financial Analysis
10.4.5.3 Products & Services Offered
10.4.5.4 Strategic Alliances between Business Partners
10.4.6.1 Business Description & Financial Analysis
10.4.6.3 Products & Services Offered
10.4.6.4 Strategic Alliances between Business Partners
10.4.7 THERMO FISHER SCIENTIFIC INC.
10.4.7.1 Business Description & Financial Analysis
10.4.7.3 Products & Services Offered
10.4.7.4 Strategic Alliances between Business Partners
10.4.7.1 Business Description & Financial Analysis
10.4.7.3 Products & Services Offered
10.4.7.4 Strategic Alliances between Business Partners
10.4.9 Argon Medical Devices, Inc.
10.4.9.1 Business Description & Financial Analysis
10.4.9.3 Products & Services Offered
10.4.9.4 Strategic Alliances between Business Partners
10.4.10 F. Hoffmann-La Roche Ltd.
10.4.10.1 Business Description & Financial Analysis
10.4.10.3 Products & Services Offered
10.4.10.4 Strategic Alliances between Business Partners
10.4.11.1 Business Description & Financial Analysis
10.4.11.3 Products & Services Offered
10.4.11.4 Strategic Alliances between Business Partners
LIST OF TABLES
1 Global Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Mllion)
2 PCR Market, By Region, 2020-2028 (USD Mllion)
3 NGS Market, By Region, 2020-2028 (USD Mllion)
4 In situ hybridization Market, By Region, 2020-2028 (USD Mllion)
5 others Market, By Region, 2020-2028 (USD Mllion)
6 Global Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Mllion)
7 Screening Market, By Region, 2020-2028 (USD Mllion)
8 Diagnostic and Predictive Market, By Region, 2020-2028 (USD Mllion)
9 Others Market, By Region, 2020-2028 (USD Mllion)
10 Global Breast cancer molecular diagnostics market, By end-user, 2020-2028 (USD Mllion)
11 Hospitals & Clinics Market, By Region, 2020-2028 (USD Mllion)
12 Diagnostic Centers and Medical Laboratories Market, By Region, 2020-2028 (USD Mllion)
13 Others Market, By Region, 2020-2028 (USD Mllion)
14 Regional Analysis, 2020-2028 (USD Mllion)
15 North America Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
16 North America Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
17 North America Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
18 North America Breast cancer molecular diagnostics market, By Country, 2020-2028 (USD Million)
19 U.S Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
20 U.S Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
21 U.S Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
22 Canada Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
23 Canada Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
24 Canada Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
25 Mexico Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
26 Mexico Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
27 Mexico Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
28 Europe Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
29 Europe Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
30 Europe Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
31 Germany Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
32 Germany Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
33 Germany Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
34 UK Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
35 UK Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
36 UK Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
37 France Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
38 France Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
39 France Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
40 Italy Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
41 Italy Breast cancer molecular diagnostics market, By Application Type, 2020-2028 (USD Million)
42 Italy Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
43 Spain Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
44 Spain Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
45 Spain Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
46 Rest Of Europe Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
47 Rest Of Europe Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
48 Rest of Europe Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
49 Asia Pacific Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
50 Asia Pacific Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
51 Asia Pacific Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
52 Asia Pacific Breast cancer molecular diagnostics market, By Country, 2020-2028 (USD Million)
53 China Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
54 China Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
55 China Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
56 India Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
57 India Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
58 India Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
59 Japan Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
60 Japan Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
61 Japan Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
62 South Korea Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
63 South Korea Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
64 South Korea Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
65 Middle East & Africa Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
66 Middle East & Africa Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
67 Middle East & Africa Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
68 Middle East & Africa Breast cancer molecular diagnostics market, By Country, 2020-2028 (USD Million)
69 Saudi Arabia Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
70 Saudi Arabia Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
71 Saudi Arabia Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
72 UAE Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
73 UAE Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
74 UAE Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
75 Central & South America Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
76 Central & South America Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
77 Central & South America Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
78 Central & South America Breast cancer molecular diagnostics market, By Country, 2020-2028 (USD Million)
79 Brazil Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)
80 Brazil Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)
81 Brazil Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)
82 Hologic Inc.: Products & Services Offering
83 Genomic Health: Products & Services Offering
84 BD: Products & Services Offering
85 Danaher: Products & Services Offering
86 Koninklijke Philips N.V.: Products & Services Offering
87 QIAGEN: Products & Services Offering
88 THERMO FISHER SCIENTIFIC INC.: Products & Services Offering
89 Myriad Genetics: Products & Services Offering
90 Argon Medical Devices, Inc.: Products & Services Offering
91 F. Hoffmann-La Roche Ltd.: Products & Services Offering
92 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Breast cancer molecular diagnostics market Overview
2 Global Breast cancer molecular diagnostics market Value From 2020-2028 (USD Mllion)
3 Global Breast cancer molecular diagnostics market Share, By Technology (2022)
4 Global Breast cancer molecular diagnostics market Share, By Application (2022)
5 Global Breast cancer molecular diagnostics market Share, By End-User (2022)
6 Global Breast cancer molecular diagnostics market, By Region (Asia Pacific Market)
7 Technological Trends In Global Breast cancer molecular diagnostics market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Breast cancer molecular diagnostics market
11 Impact Of Challenges On The Global Breast cancer molecular diagnostics market
12 Porter’s Five Forces Analysis
13 Global Breast cancer molecular diagnostics market: By Technology Scope Key Takeaways
14 Global Breast cancer molecular diagnostics market, By Technology Segment: Revenue Growth Analysis
15 PCR Market, By Region, 2020-2028 (USD Mllion)
16 NGS Market, By Region, 2020-2028 (USD Mllion)
17 In situ Hybridization Market, By Region, 2020-2028 (USD Mllion)
18 Others Market, By Region, 2020-2028 (USD Mllion)
19 Global Breast cancer molecular diagnostics market: By Application Scope Key Takeaways
20 Global Breast cancer molecular diagnostics market, By Application Segment: Revenue Growth Analysis
21 Screening Market, By Region, 2020-2028 (USD Mllion)
22 Diagnostic and Predictive Market, By Region, 2020-2028 (USD Mllion)
23 Others Market, By Region, 2020-2028 (USD Mllion)
24 Global Breast cancer molecular diagnostics market: By End-User Scope Key Takeaways
25 Global Breast cancer molecular diagnostics market, By End-User Segment: Revenue Growth Analysis
26 Hospitals & Clinics Market, By Region, 2020-2028 (USD Mllion)
27 Diagnostic Centers and Medical Laboratories Market, By Region, 2020-2028 (USD Mllion)
28 Others Market, By Region, 2020-2028 (USD Mllion)
29 Regional Segment: Revenue Growth Analysis
30 Global Breast cancer molecular diagnostics market: Regional Analysis
31 North America Breast cancer molecular diagnostics market Overview
32 North America Breast cancer molecular diagnostics market, By Technology
33 North America Breast cancer molecular diagnostics market, By Application
34 North America Breast cancer molecular diagnostics market, By End User
35 North America Breast cancer molecular diagnostics market, By Country
36 U.S. Breast cancer molecular diagnostics market, By Technology
37 U.S. Breast cancer molecular diagnostics market, By Application
38 U.S. Breast cancer molecular diagnostics market, By End User
39 Canada Breast cancer molecular diagnostics market, By Technology
40 Canada Breast cancer molecular diagnostics market, By Application
41 Canada Breast cancer molecular diagnostics market, By End User
42 Mexico Breast cancer molecular diagnostics market, By Technology
43 Mexico Breast cancer molecular diagnostics market, By Application
44 Mexico Breast cancer molecular diagnostics market, By End User
45 Four Quadrant Positioning Matrix
46 Company Market Share Analysis
47 Hologic Inc.: Company Snapshot
48 Hologic Inc.: SWOT Analysis
49 Hologic Inc.: Geographic Presence
50 Genomic Health: Company Snapshot
51 Genomic Health: SWOT Analysis
52 Genomic Health: Geographic Presence
53 BD: Company Snapshot
54 BD: SWOT Analysis
55 BD: Geographic Presence
56 Danaher: Company Snapshot
57 Danaher: Swot Analysis
58 Danaher: Geographic Presence
59 Koninklijke Philips N.V.: Company Snapshot
60 Koninklijke Philips N.V.: SWOT Analysis
61 Koninklijke Philips N.V.: Geographic Presence
62 QIAGEN: Company Snapshot
63 QIAGEN: SWOT Analysis
64 QIAGEN: Geographic Presence
65 THERMO FISHER SCIENTIFIC INC. : Company Snapshot
66 THERMO FISHER SCIENTIFIC INC. : SWOT Analysis
67 THERMO FISHER SCIENTIFIC INC. : Geographic Presence
68 Myriad Genetics: Company Snapshot
69 Myriad Genetics: SWOT Analysis
70 Myriad Genetics: Geographic Presence
71 Argon Medical Devices, Inc.: Company Snapshot
72 Argon Medical Devices, Inc.: SWOT Analysis
73 Argon Medical Devices, Inc.: Geographic Presence
74 F. Hoffmann-La Roche Ltd.: Company Snapshot
75 F. Hoffmann-La Roche Ltd.: SWOT Analysis
76 F. Hoffmann-La Roche Ltd.: Geographic Presence
77 Other Companies: Company Snapshot
78 Other Companies: SWOT Analysis
79 Other Companies: Geographic Presence
The Global Breast Cancer Molecular Diagnostics Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Breast Cancer Molecular Diagnostics Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
